In men who are overweight or obese, adding testosterone therapy reduced glucose intolerance/T2DM

Tomás P Griffin; Sean F Dinneen

doi:10.7326/ACPJ202105180-054

In men who are overweight or obese, adding testosterone therapy reduced glucose intolerance/T2DM

Ann Intern Med. 2021 May;174(5):JC54. doi: 10.7326/ACPJ202105180-054. Epub 2021 May 4.

Authors

Tomás P Griffin¹, Sean F Dinneen¹

Affiliation

¹ Galway University Hospitals, Galway, Ireland (T.P.G., S.F.D.).

PMID: 33939479
DOI: 10.7326/ACPJ202105180-054

Abstract

Wittert G, Bracken K, Robledo KP, et al. Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial. Lancet Diabetes Endocrinol. 2021;9:32-45. 33338415.

Publication types

Comment

MeSH terms

Diabetes Mellitus, Type 2* / drug therapy
Double-Blind Method
Glucose Intolerance* / drug therapy
Humans
Male
Obesity / complications
Obesity / drug therapy
Overweight / complications
Overweight / drug therapy
Testosterone / therapeutic use

Substances

Testosterone